510(k) device
Fitbit Irregular Rhythm Notifications
Fitbit, Inc. · Photoplethysmograph Analysis Software For Over-The-Counter Use (QDB, Class II) · First FDA decision Apr 8, 2022, newest Apr 8, 2022Atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
4
Naming "Irregular Rhythm Notifications"
MAUDE reports
0
Brand "Irregular Rhythm Notifications", since 2015
PubMed studies
3
Mentioning "Irregular Rhythm Notifications"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Fitbit Irregular Rhythm Notifications
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K212372 · Decided Apr 8, 2022 · 252 days after receipt
Device type: Photoplethysmograph Analysis Software For Over-The-Counter Use (QDB) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Irregular Rhythm Notifications", any status and sponsor, newest update first.
Emory UniversityAcademic, hospital or other
NCT05795842 · 500 participants (planned) · Start Mar 21, 2023 · Primary completion Dec 2027
Device: wearable wristband model; Standard of care extended ECG monitoring · For: Stroke, Ischemic
Sites: Atlanta, Georgia
- Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable (Apple Watch)Pivotal-lookingCompleted
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)Academic, hospital or other
NCT05686330 · 436 participants · Start Nov 16, 2022 · Primary completion Jul 17, 2025
Device: Apple Watch · For: Atrial Fibrillation
Sites: Amsterdam, Netherlands; Haarlem, Netherlands
VitalConnect Inc.Not on our public-company list
NCT04556240 · 0 participants · Start Sep 15, 2020 · Primary completion Oct 30, 2020
Device: VitalConnect Platform · For: Arrhythmias, Cardiac
Sites: Chevy Chase, Maryland
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Irregular Rhythm Notifications", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QDB
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Irregular Rhythm Notifications"[tiab]. The summary above synthesizes these.
- Individualized prediction of atrial fibrillation onset risk based on lifelogs.
Kimura T, Jinzaki M, Miyama H, et al. · Am J Prev Cardiol · 2025
- Physician responses to apple watch-detected irregular rhythm alerts.
Demkowicz PC, Dhruva SS, Spatz ES, et al. · Am Heart J · 2023Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- Wearable Devices, Health Care Use, and Psychological Well-Being in Patients With Atrial Fibrillation.
Rosman L, Lampert R, Zhuo S, et al. · J Am Heart Assoc · 2024Research Support, N.I.H., Extramural
Other devices of this type
Also filed under product code QDB.
- Irregular Rhythm Notification Feature (IRNF)Apple, Inc. · De Novo 2023
- Atrial Fibrillation History FeatureApple, Inc. · 510(k) 2022
- IRNF AppApple, Inc. · 510(k) 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.